← SynDRA
crizotinib..S.
SynDRA canonical compound SYN1970421 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | NUDT1 |
| Mechanism of action | MTH1 inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- (S)-crizotinib
- ent-crizotinib
- 3-[(1s)-1-(2,6-Dichloro-3-Fluorophenyl)ethoxy]-5-(1-Piperidin-4-Ylpyrazol-4-Yl)pyridin-2-Amine
- CHEMBL1825141
- CHEBI:77555
- 3-[(1S)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine
- 2-Pyridinamine, 3-[(1S)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-
- 3-[(1S)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-amine
- (S)-3-(1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY)-5-(1-(PIPERIDIN-4-YL)-1H-PYRAZOL-4-YL)PYRIDIN-2-AMINE
- crizotinib-(S)
- S-CRIZOTINIB
- GTPL7581
- SCHEMBL14811801
- EX-A5639
- ZEC35645
- BDBM50352564
- NSC794690
- s7505
- ZINC35902488
- (S)-Crizotinib, >=98% (HPLC)
- AKOS025401749
- CCG-269234
- NSC-794690
- NCGC00384190-02
- NCGC00384190-03
- AC-25088
- AC-33076
- HY-100549
- CS-0019694
- J3.637.461F
- A14291
- E98965
- BRD-K40308497-001-02-0
- Q27467066
- (S)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-am ine
- VHS
Look up crizotinib..S. in the interactive SynDRA portal →